Pre-emptive analgesia using intravenous fentanyl plus low-dose ketamine for radical prostatectomy under general anesthesia does not produce short-term or long-term reductions in pain or analgesic use by Katz, Joel et al.
Pre-emptive analgesia using intravenous fentanyl plus low-dose ketamine
for radical prostatectomy under general anesthesia does not produce
short-term or long-term reductions in pain or analgesic use
JoelKatz"'o'"'*, Roger Schmido't, Ditk G. Snijdelaard, Terence J. Coderre",
Colin J.L. McCartneyb'", Adarose Wowkb'2
"Department of Psychology and School of Kinesiology and Health Science, York University, Toronto, Ont., Carnda
bDepartment of Anesthesia and Pain Management, University Health Ne*vork and Mount Sinai Hospital, Toronto, Ont., Canada
"Department of Anesthesia, University of Toronto, Toronto, Ont,, Canada
dDepartment of Anesthesiology/Pain Centre, IJniversity Medical Centre Nijmegen, Nijmegen, The Netherlands
eDepartments of Anesthesia' Neurolosv and Neuros1::fl'H'.;:,:,-y:;*;"Yi7l!Iii,flii;f:.o!jl#:*"tv Health centre Research Institute and McGiII
Abstract
The aim ofthe study was to evaluate post-operative pain and analgesic use after pre-operative or post-incisional i.v. fentanyl plus low dose i.v.
ketamine vs. a standard treatment receiving i.v. fentanyl but not ketamine. Men undergoing radical prostatectomy under general anesthesia were
randomly assigned in a double-blinded manner to one ofthree groups. Patients received i.v. fentanyl before incision followed by an i.v. bolus dose
(0.2 ml kg-l) and an i.v. infusion (0.0025 rnl kg-r min-r; of 1 mg ml-l ketamine (group 1) ornormal saline (groups 2 and3). Seventy minutes after
incision, patients received i.v. fentanyl followed by an i.v. bolus dose (0.2 ml kg-t) and an i.v. infusion (0.0025 rnl kg-t min-t; of saline (groups I
and 3) or ketamine (group 2). Pain, von Frey pain thresholds, and cumulative morphine consumption using patient-controlled analgesia (PCA) were
assessed upto72 hafter surgery. 143 patients completedthe study (group 7,n: 47:group2,n: 50; group 3, n : 46). CumulativePCAmorphine
(mean + SD)didnotdiffersignificantlyamonggroups(group1,92.3 + 45.9mg; group2,l07.2 r- 58.4mg;group3,103.6 + 50.4mg;P:0.08
for groups 1 vs. 2, and groups 1 vs. 3). On day 3, the hourly rate (mean + SEM) of morphine consumption was significantly lower (P < 0.0009) in
group I (0.61 -'- 0.013 mg h-') than group 2 (0.86 -r- 0.01 I mg h-r) and group 3 (0.89 * 0.008 mg h-r;. Pain scores and von Frey pain thresholds
did not differ significantly among groups. Two-week and 6-month follow-ups did not reveal significant group differences in pain incidence, intensity,
disability or mental health. Pre-operative, low-dose administration of i.v. ketamine did not result in a clinically meaningful reduction in pain or
morphine consumption when compared with post-incisional administration of ketamine or a saline confrol condition.
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1. Introduction
Ketamine hydrochloride operates on multiple receptor
systems (Schmid et al., 1999). However, its property as a
non-competitive NMDA receptor antagonist generated
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a new focus of research activity once this receptor-ion
channel complex was found to play a critical role in the
induction and maintenance of central sensitization and
pathological pain (Wilcox, I99l; Woolf and Thompson,
1991). The mechanism by which pain and analgesic
consumption are reduced after pre-emptive administration
of local anesthetics and opioids is believed to involve the
prevention of NMDA-mediated sensitization of spinal cord
dorsal horn neurons (Kissin, 2000; Woolf and Chong,
1993). Thus, the NMDA channel blocker ketamine has been
of particular interest in evaluating the hypothesis that
ketamine administration before surgery would reduce pain
and analgesic consumption relative to saline administration
or to ketamine administration after incision.
Studies of pre-emptive analgesia using intravenous low-
dose ketamine have yielded mixed results (Katz, 2003;
McCartney et a1.,2004; Schmid et al., 1999) This is in part
due to the large inter-study variability in surgical procedure,
patient population, dose of ketamine, use of additional
analgesic agents intraoperatively and study design. One of
the aims of the present study was to evaluate the effects on
post-operative pain and morphine consumption of pre-
incisional vs. post-incisional i.v. administration of the mu
opioid agonist fentanyl plus low-dose ketamine. Use of
these two agents together would be expected to capitalize on
their combined actions in reducing nociceptive input and
central sensitization (Chapman and Dickenson, 1992;
Dickenson, 1997). We hypothesized that morphine con-
sumption would be lower in the pre-incisional group
compared with the post-incisional group.
Debate about the efficacy of pre-emptive analgesia stems
in part from a fundamental misconception about its
definition (Katz, 2003; Kissin, 2000). The typical two-
group design that compares administration of an agent
before vs. after incision or surgery fails to control for the
possibility that early and late noxious intraoperative stimuli
contribute equally to post-operative central sensitization.
Two group studies that do not show a significant difference
in outcome leave open the question of whether the absence
of an effect reflects the relative efficacy of post-operative
blockade or the inefficacy of pre-operative blockade in
reducing central sensitization (Katz, 2003: Katz et al.,
2003).
Therefore, the second aim of the present study was to
evaluate post-operative pain and analgesic use after pre-
operative or post-incisional i.v. fentanyl plus low dose i.v.
ketamine vs. a standard treatment control condition
consisting of i.v. fentanyl but not ketamine. Men under-
going radical prostatectomy under general anesthesia were
randomly assigned in a double-blinded manner to one of
three groups: (l) i.v. fentanyl plus low dose i.v. ketamine
(bolus plus infusion) before incision and i.v. fentanyl plus
saline (bolus plus infusion) after incision; (2) i.v. fentanyl
plus i.v. saline (bolus plus infusion) before incision and i.v.
fentanyl plus low dose i.v. ketamine (bolus plus infusion)
after incision; or (3) i.v. fentanyl plus i.v. saline (bolus plus
infusion) before and after incision. We hypothesized that
post-operative pain and morphine consumption would be
lowest in the pre-incision group and highest in the control
group.
2. Materials and methods
Approval to carry out the study was obtained from The
Toronto Hospital Research Ethics Board. All patients gave
their written informed consent to participate before entering
the study.
Patients scheduled for radical prostatectomy for prostate
cancer were eligible for recruitment into the study. Inclusion
criteria were American Society of Anesthesiologists
physical status I-II, age between 19 and 75 years and
--- able to speak and read English. Exclusion criteria were
contraindications to (iv) patient-controlled analgesia (PCA)
with morphine, American Society of Anesthesiologists
physical status )II, history of major psychiatric disorder,
and chronic opioid use.
2.1. Randomization and blinding procedures
A randomization schedule was computer-generated
(Dallal, 1988) and provided to the hospital pharmacist
who prepared and dispensed the study drug. The randomiz-
ation schedule specified the group (1,2, or 3) to which each
prospective patient would be allocated upon entry into the
trial. An opaque envelope containing the patient number and
group assignment was prepared, sealed and numbered for
each patient by the hospital pharmacist.
All patients and personnel involved in patient manage-
ment and data collection were unaware of the group to
which the patient had been allocated. The anesthesiologist
in charge ofthe case was also unaware ofgroup allocation.
2.2. Drug preparation
A standard volume of ketamine hydrochloride and
normal saline was prepared in two separate 60 ml syringes,
coded for blinding purposes, and dispensed by the hospital
pharmacy on the day of surgery. The syringes were labeled
'pre-incision' and 'post-incision'. For group I and 2
patients, one syringe contained 60 ml ketamine hydrochlo-
ride (1 mg ml-'); the second contained 60 ml normal saline.
For group 3 patients, both syringes contained 60 ml normal
saline. The pharmacist who dispensed the study medications
was not involved in any other aspect of the study.
2.3. Pain assessment instruments
2.3.1. Visual analogue scale (VAS)
The VAS provides a simple, efficient, and minimally
intrusive measure of pain intensity that has been used
widely in research settings where a quick index of pain is
required and to which a numerical value can be assigned
(Katz and Melzack, 1999). The VAS consists of a 10 cm
horizontal line with the two endpoints labeled 'no pain' and
'worst possible pain', respectively. The patient is required to
mark the l0 cm line at a point that corresponds to the level
of pain intensity he presently feels. The distance in
centimeters from the low end of the VAS and the patient's
mark is used as a numerical index of pain intensity. Pain was
assessed with patients at rest (VAS-R) and after standard
mobilization (VAS-M) by asking patients to roll from a
supine to a sideJying position and perform two maximal
inspirations before rating their pain.
2.3.2. McGill Pain Questionnaire (MPQ)
The MPQ was developed by Melzack (1975) to obtain
quantitative and qualitative measures of the experience of
pain. The MPQ yields two global scores, the pain rating
index (PRI) and the present pain intensity (PPI); which have
been found to provide valid and reliable measures of pain
(Katz and Melzack, 1999 Melzack, 1975). The PRI is the
sum of the rank values of the words chosen from 20 sets of
qualitative words, each set containing 2-6 adjectives that
describe the sensory, affective and evaluative properties of
pain. The lists of pain descriptors are read to the patients
who are asked to choose the word in each category that best
describes their pain at the moment. The PPI is rated on a
scale of 0-5 as follows: 0, none; 1, mild; 2, discomforting;
3, distressing; 4, horrible; and 5, excruciating.
2.3.3. von Frey filaments
Secondary mechanical hyperalgesia to punctate stimu-
lation applied to the skin was assessed using von Frey
filaments (Smith and Nephew Rolyan Inc., Menomonee
Falls, WI) that consist of a set of 20 individual nylon
filaments of equal length (38 mm) ranging from 0.06 to
1.14 mm in diameter. Each filament has been assigned a
value that represents the logarithm of the force (in mg)
required to bend it maximally when pressed against the skin.
To minimize the assessment burden on the patients, we used
every other filament beginning with the smallest (0.06 mm).
On each trial, a filament was applied to the designated point
on the skin for approximately I s. Trials were separated by
an interval ranging from 5 to 15 s in order to reduce the
likelihood of anticipatory responses. Filaments were applied
in ascending serial order. Touch threshold (TT) was defined
by the value (force in log mg) associated with the filament
that patients first reported a sensation of touch. Pain
threshold (PT) was defined by the value (force in log mg)
associated with the filament that patients first reported as
being uncomfortable or painful. PTs were obtained from
two regions of the body: a control site on the inner forearm
and a test site approximately 10 cm from the wound
dressing.
2.4. Measures of psychosocial functioning
2.4.1. Mental Health Inventory (MHI)
The MHI (Ware et al., 1979) is a self-administered
questionnaire that measures symptoms of psychological
distress and well-being. The present study used an 18-item
version of the MHI that consists of a total score and five
subscales: anxiety, depression, loss of behavioral/emotional
control, positive affect, and interpersonal ties (Weinstein
et al., 1989). Subjects responded to each of the 18
statements on the basis of how often 'in the past month'
they have experienced each symptom. Each statement is
accompanied by a six choice response set ranging from
1 : all of the time to 6 : none of the time. The total score.
which we report in the present study, ranges from 0 to 108
with higher scores indicative of better mental health. The
MHI was administered prior to surgery. Internal reliability
of the MHI subscales by Cronbach's alpha ranged from 0.10
(loss of behavioraVemotional control) to 0.85 (depression).
2.4.2. Spielberger State-Trait Anxiety Inventory 6TAI)
The STAI (Spielberger et al., 1970) is composed of two
forms, each of which measures separate dimensions of
anxiety. The STAI-S consists of 20 statements and measures
'state anxiety'. The patients are required to respond on the
basis of how they are feeling 'right now' (i.e. at the moment
when completing the form). The STAI-T measures anxiety
as an enduring personality trait and consists of another 20
statements that pertain to how the patients 'generally feel'.
The STAI-S has been shown to be sensitive to psychological
manipulations that alter anxiety level. Test-retest reliability
coefficients of the STAI-T have been reported to
be relatively high, reaching approximately 0.70 after a
3-month interval, and increasing with decreasing time
between testings. The STAI has also shown relatively
high correlations with other well known measures of
anxiety. Only the STAI-S was used in the present study.
Internal reliability of the STAI-S by Cronbach's alpha was
0.90.
2.4.3. Follow-up Pain Questionnaire (FUPQ)
The FUPQ is a brief inventory designed to assess the
presence, intensity, location, frequency, and quality oflong-
term post-surgical pain. Items also assess pain interference
in daily life, methods of pain relief sought, medication use
and aggravating and relieving factors. The FUPQ was
modeled after similar pain assessment measures including
the MPQ (Melzack, 1975) and a follow-up interview form
used to assess long-term pain after surgery (Dajczman et al.,
1991). The FUPQ was administered at the 6-month post-
surgical interview.
2.5. Procedures
2. 5. L Preoperative assessment
A member of the research team approached prospective
patients who were informed of the nature of the study,
screened for eligibility and recruited if interested. Following
informed written consent, patients completed the MHI and
STAI-S. Patients were familiarized with the VAS rating
scales and were shown a PCA pump and instructed in its use.
2. 5. 2. P re - in c i s i o nal and p o st - inci s ionql admini str ati o n
of ketamine and saline
On the morning of surgery a research nurse drew up the
appropriate volumes (based on the patient's weight) from
the two 60 ml coded syringes that had been prepared and
dispensed by the pharmacy. The first and second syringes,
labeled'pre-incision' and'post-incision', respectively,
contained ketamine (l mg ml-l) and saline for group 1,
bolus Start 1e intssion bolus Start 2d infusion bolus 2rr infusion
Fig. l. Flow chart showing timing of drug administration relative to specific pre-operative and intraoperative events. To ensure comparability among groups!
time intervals TerTdz, Ta3 and Zsq, ZB2 were designed to be ofequal duration, respectively. See Table I for actual duration ofeach interval. Abbreviations: F,
fentanyl; K, ketamine; S, saline; subscript b, bolus; subscript i, infusion.
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saline and ketamine (1 mg ml-') for group 2, and saline and
saline for group 3.
All patients received i.v. fentanyl (1 pg kg-t,
25 pg ml-') every 80 min starting approximately 5 min
before induction of general anesthesia (Fig. I and Table l).
Approximately l0 min before skin incision, and after
induction of general anesthesia, all 
_patients received a
bolus dose of i.v. fentanyl (0.5 p.g kg-'). This was followed
immediately by an i.v. bolus dose (0.2 ml kg-') and an i.v.
infusion (0.0025 ml kg-t min-t) from the first syringe
labeled 'pre-incision'. Seventy minutes after incision, the
first infusion was stopped and all patients received a bolus
dose of i.v. fentanyl (0.5 pg tg-r;. ttris was followed
immediately by an i.v. bolus dose (0.2 ml kg-r) and an i.v.
infusion (0.0025 ml kg-t min-l; from the second syringe
labeled 'post-incision'. The second infusion was stopped
after 80 min, approximately 150 min after incision.
2.5.3. General anesthesia
Patients received midazolam l-2mg i.v. as pre-
medication approximately t h before surgery. General
anesthesia was induced with thiopental 4-6mgkg-r.
Intubation followed the administration of d-tubo curarine
(3.0-4.5 mg) and succinylcholine 1.0-1.5 mg kg-r. Gen-
eral anesthesia was maintained with 60Vo N2O in 02 and
isoflurane. Pancuronium was used for neuromuscular
blockade. Vasoactive agents (beta-blockers, vasodilators
and vasopressors) were used as required to maintain
Table I
Timing of drug administration relative to intraoperative events (mean + SD)
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hemodynamic parameters within -r20Vo of mean pre-
operative baseline values. At the conclusion of the surgery,
neuromuscular blockade was reversed with neostigmine
0.05 mgkg-r and glycopyrrolate 0.02 mg kg-l. The tra-
chea was extubated after emergence and upon resumption of
spontaneous breathing. Patients received supplemental 02
by mask and were transported to the post-anesthetic care
unit (PACU).
2. 5.4. Intraop erative monitoring
All patients were continuously monitored with an arterial
line (systolic, mean, diastolic blood pressure), electrocar-
diogram (heart rate and rhythm), pulse oximeter, nasal
temperature probe, and end-tidal monitor (anaesthetic gas
and carbon dioxide levels). Intra-operative hemodynamics
and end-tidal isoflurane were recorded every minute for the
first 5 min after skin incision and everv 15 min thereafter
until the end of surgery.
2. 5. 5. Postoperative analgesia
Patients were assessed immediately upon arrival in the
PACU and were connected to a PCA pump system (Abbott
Life Care Infuser, Abbott Laboratories, Chicago, IL, USA).
If patients complained of pain, a research nurse blind to
group allocation administered a loading dose of 2-4 mg
morphine. Every 5 min, patients were asked whether
they were in need of pain relief. An affirmative response
was followed by a 1.0-1.5 mg i.v. bolus of morphine.
Time interval (see Fig. l) lnterval between intraoperative events Group I Group 2 Group 3
Ta.t
r Bl
Taz
Tsz
Tx
Til { 762
Tsz*TB
Min between pre-induction dose of fentanyl and induction of GA
Min between pre-induction dose offentanyl and start of infusion I
Min between start of infusion 1 and incision
Min between start of infusion I and lst post-incisional dose offentanyl
Min between 2nd post-incisional dose offentanyl and start of infusion 2
Min between start of infusion 2 and 3rd post-incisional dose offentanyl
Min between 3rd post-incisional dose offentanyl and end of infusion 2
Duration in min of first infusion
Duration in min of second infusion
4.6 ! 3.7
22.6 + 6.1
9.9 + 6.4
58.6 + 3.8
22.6 + 6.7
58.2 + 5.2
23.1 + 7.8
81.2 + 8.3
81.3 + 8.0
4.8 + 3.9 4.8 +
25.1 + 7.0 23.2 +
9.2 + 2.6 9.7 +
58.9 + 3.4 59.4 +
25.4 + 7.3 23.2 !
59.0 + 4.0 59.4 +
26.6 + 17.8 23.0 +
84.2 + 7.9 82.6 +
85.5 + 17.7 82.4 +
3.5
8.2
3.3
3.3
8.2
3.3
8.4
8.3
8.8
This procedure was repeated until the patients were alert
enough to begin self-administration using the PCA pump
button. The PCA pump was set to deliver a 1.0-1.5 mg i.v.
bolus dose of morphine with a lock-out time of 5 min, a
maximum dose of 40 mg in any 4 h period, and no
continuous background infusion. This regimen was over-
seen by the Acute Pain Service and was continued on the
ward for 72 h during which time no other analgesics were
administered. Morphine consumption in milligrams was
calculated on an hourly basis from hard copy records
(Abbott TRW Printer, Model TP 40, Abbott Laboratories,
Chicago, IL, USA) of the 72 h study period.
2.5.6. Measurement of post-operative pain and von Frey
thresholds
VAS-R was measured 3, 6, 12, 24,48, and 72h after
surgery. VAS-M, MPQ, von Frey TT and PT were measured
at 24, 48, and 72 h after surgery.
2. 5.7. Two -w e ek follow - up
Patients were seen in the hospital on their first visit post-
discharge approximately 2 weeks after surgery. An assess-
ment of pain status since discharge was obtained and von
Frey touch (TT) and pain (PT) thresholds were measured as
previously described.
2. 5. 8. Six-month follow-up
Patients were contacted by telephone approximately 6
months from the date of surgery and administered the post-
surgical follow-up questionnaire. A maximum of five
attempts was made to contact each patient by telephone.
2.5.9. Sample size calculation
Sample size estimation was performed using data from
an earlier study of men undergoing radical prostatectomy
who received pre-incisional or post-incisional lumbar
epidural bupivacaine (Katz et al., 1994). In that study,
mean cumulative PCA morphine was 55 mg for the pre-
incisional group and 7l mg for the post-incisional group
with a standard deviation of 28 mg. The 16 mg difference in
morphine consumption represented a savings of 30Vo in
favor of the pre-incisional group. Using a type I error rate of
0.05 we estimated that we would require 45 patients per
group to detect a mean difference of 16 mg (SD 28 mg) with
a power of 
-807o (Brown et al., 1993). Two Monte Carlo
simulations (Hammersley and Handscomb,1964) of 10,000
trials each were then performed under the following two
conditions assuming 45 patients per group and a standard
deviation of 28 mg: (1) pre-incision mean 55 mg, post-
incision mean 7l mg, control mean 85 mg; and (2) pre-
incision mean 55 mg, post-incision mean : control
mean:7lmg. Comparisons between pairs of means
were undertaken when the omnibus F-test was statistically
significant (i.e. a:0.05, two tailed). The Monte Carlo
simulations indicated that a sample size of 45 patients per
group provided a power of 80Vo under condition 7 and 99Vo
under condition 2.
2.5.10. Data entry and veification
Data werekeyed in twice. One of the data sets was checked
for errors manually by two research assistants/nurses. After
correcting any errors, the two data sets were compared field by
field by an in-house computer program. Discrepancies
between matching records in the two data sets were corrected
by referring back to the raw data.
2.5. 1 I. Statistical analysis
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS for Windows, release 11.0.1,
Chicago, IL) and Primer of Biostatistics: The Program
(Version 4.0, McGraw Hill, New York, NY, USA) (Glantz,
1997). Background demographic data and clinical variables
were compared using ANOVA for parametric data and
f -test for nominal data.
Primary outcome variable. Cumulative morphine con-
sumption at 72h after surgery was analyzed by one-way
ANOVA followed by directional comparisons between
pairs of means.
Secondary outcome variables. Visual analogue pain
scores at rest (VAS-R), after movement (VAS-M) and von
Frey touch (TT) and pain thresholds (PT) were analyzed by
2-way between-within ANOVA using group as the between
subjects factor and time after surgery as the within subjects
factor. The regression lines relating time and cumulative
morphine consumption on day 3 after surgery (between 49
and72 h) were compared pair wise by one-way ANOVA by
first testing the overall coincidence of the regression lines
(Glantz,1997). Ifthe overall coincidence differed, the slopes
and intercepts were compared by r-test using the Bonferroni
type I error rate correction for multiple comparisons
(a : 0.05/number of comparisons). MPQ pain rating indexes
(PRIs) and MPQ present pain intensity (PPI) were analyzed
by non-parametric Kruskal-Wallis ANOVA of ranks. MHI
and STAI-S scores were analyzed by one-way ANOVA.
All data presented are mean + SD unless otherwise
specified. P < 0.05 is considered statistically significant.
3. Results
3.1. Recruitment and patient with.drawals
Between June 1994 and October 1991 ,168 patients were
recruited into the study. In total25 patients were withdrawn
for the following reasons.
Pre-randomization dropouts (n:8) : Procedure can-
celled on the day of surgery (n:2); pharmacy did not
prepare the drugs in time for the surgery (n:2); personnel
not available to run the case (n:4).
Intraoperative withdrawals (n: 10) : Excessive bleed-
ing and/or change in operative procedure (n: 4);
administration of additional analgesic agents (n:3);
problems with the infusion pump (re :2)i anaphylactic
reaction to general anesthesia (n: l).
Postoperative withdrawals (n:7) : bleeding (n : l);
faulty PCA equipment (n = l); severe bladder spasms
requiring additional analgesics (n:3); alcohol withdra-
wal/delirium tremens (n: l); excessive drowsiness pre-
cluding data collection (z: 1).
There were no significant differences among groups in
the proportion of patients withdrawn (n:7, 6, and 4 for
groups I 
-3, respectively).
In total, 143 patients completed the study; 47 in group 1,
50 in group 2 and 46 in group 3.
3.2. Timing of drug adminisnation relative to intraoperative
events
Table I and Fig. I show the intervals between specific
intraoperative events as they relate to the time of
administration of fentanyl, ketamine and saline. As
designed, there were no significant group differences
between any of the intervals, including, the time between
the pre-induction dose of fentanyl and induction, the time
between the start of the first infusion and incision. and the
duration of the first and second infusions.
3. 3. Demo graphic, psychosocial and intraope rative
variables
There were no significant differences among the groups
in demographic or clinical data (Table 2) or pre-operative
MHI and STAI-S scores (Table 3). The groups did not differ
significantly in the total dose of i.v. fentanyl. Groups I and2
did not differ significantly in the total dose of ketamine
received.
Figs. 2 and 3 show mean percent end tidal isoflurane and
the mean change from pre-operative baseline level in heart
rate and mean blood pressure across the surgical procedure.
There were no significant differences among the three
groups in any of these parameters.
Table 2
Demographic and clinical variables
Demographic/
clinical measure
Group I Group 2 Group 3
Table 3
Scores (mean + SD) on the Spielberger State Anxiety Inventory (STAI-S)
and Mental Health Inventory (MHI) obtained the evening before surgery
Psychosocial measure Group I Group 2 Group 3
STAI-S
MHI-anxiety
MHI-depression
MHI-loss of control
MHl-positive affect
MHl-total score
38.1 + 9.63
24.4 + 3.33
20.9 + 2.40
22.1 x.2.12
18.7 + 3.09
91.5 + 10.45
35.8 + 10.87
24.2 + 4.42
2t.r + 3.28
22.1 + 1.95
18.4 + 3.12
91.3 + 11.64
34.8 ! 8.77
25.4 + 3.63
21.5 + 2.70
22.2 + 1.94
19.3 + 2.34
93.9 + 9.04
3.4. PCA morphine consumption
Although cumulative PCA morphine consumption at
72h was lower in group I (92.2 +- 45.9 mg) than group 2
(107.Z + 58.4 mg) and group 3 (103.6 r- 50.4 mg), com-
parisons between the means did not reach the conventional
0.05 level of significance (P:0.08 for groups I vs. 2 and
P : 0.08 for groups I vs. 3). The number of PCA requests
that did not result in a bolus of morphine (i.e. requests made
during the 5-min lock-out period) did not differ significantly
among the groups (data not shown). Table 4 shows PCA
morphine consumption between intervals when pain at rest
was assessed. Morphine consumption did not differ
significantly during any of the intervals.
Fig. 4 shows cumulative morphine consumption for the
three groups across the 72 h study period. Also shown are
the best-fitting linear regression lines relating cumulative
morphine consumption and time for each group across the
final24 h period (day 3, 49-12 h). On day 3, the hourly
rate (mean + SEM) of morphine consumption in
group 1 (0.6t + 0.013mgh-') was significantly lower
(P < 0.0009) than that in group 2 (0.86 +- 0.011 mg h-1)
and group 3 (0.89 -f 0.008 mg h-t). Groups 2 and3 did not
differ significantly.
3.5. Postoperative pain and von Frey thresholds
There were no significant differences among the groups
in VAS pain scores (Fig. 5), MPQ pain rating indexes
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Fig. 2. Percent end-tidal isoflurane shown for the three groups during the
first and second intraoperative i.v. infusions. Downward pointing arrow at
zero on the X-axis corresponds to time of skin incision.
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Total ketamine (mg)
62 + 5.8
175 + 8.3
8t + 9.5
25:21
180 + 30.9
1507 + 983.5
364.8 + 59.66
31.9 + 4.21
62 + 6.2
I78 + 7.9
84 + 1',7.1
18:32
181 + 30.7
1770 + 1217.7
365.1 + 61.84
32.2 + 3.9
6l + 6.7
176 + 6.1
84 + 16.8
23:23
182 + 45.2
1603 + 1015.7
369.9 + 87.24
0.0 + 0.0
Data are mean + SD unless otherwise stated.
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Fig. 3. Change from baseline in mean blood pressure and heart rate shown
for the three groups during the first and second intraoperative i.v. infusions.
Downward pointing anow at zero on the X-axis corresponds to time of skin
incision.
(Table 5), or von Frey touch or pain thresholds measured
near the wound and at the control site on the inner forearm
(Fig. 6).
3. 6. Comp lic ations/adv e rs e ev ent s
The following complications/adverse events occurred
intraoperatively: excessive bleeding in two patients (one in
group I and one in group 3); anaphylactic reaction to the
general anesthetic in one patient (group 2). The following
complications/adverse events occurred post-operatively:
vivid dreams in one patient (group 2); agitation in two
patients (one in group 1 and one in group 3); drowsiness in
Table 4
PCA morphine consumption (mg) within intervals bounded by times when
pain at rest was assessed
Time interval
after surgery (h)
Group I Group 2 Group 3
110
100
90
80
70
OU
RN
40
30
zu
10
0
..o... y'= *0.61x + 48.2
+ Y'= 0.86x + 45.9
---o- Y=0.89x+40.2
Hours after surgery
Fig.4. An hour-by-hourplot ofcumulative PCA morphine consumption for
each group showing the best-fitting, least squares regression line calculated
for day 3 (49-72h after surgery). Each regression line accounts for at least
957o (f) ofthe total variance. The hourly rate ofmorphine consumption on
day 3 was significantly lower for groups 1 vs. 2 and for groups I vs. 3
reflecting the benefit of pre-operative ketamine. Bonferroni corrected
significance tests of the regression line slope comparing groups I vs. 2 and
groups I vs. 3 on day 3, *P < 0.0009.
two patients (group 1); alcohol withdrawal/delirium tremens
in one patient (group 2); and hypotension and bleeding in
one patient (group 3).
3.7. Tw o -w e ek follow-up as s e s sment
One hundred and twenty-five of the 143 patients (87 .4Eo)
were assessed at the hospital approximately 2 weeks after
discharge (n:40,43, and 42 in groups 1-3, respectively).
The overall incidence of pain was 55.27o (n:79). The pain
intensity was in the mild to moderate range. von Frey touch
and pain thresholds are shown in Fig. 6. There were no
significant differences among the three groups in any of the
variables measured 0able 6).
06 12 24 36 48 60 72
Hours after surgery
Fig. 5. Visual analogue scale (VAS) pain scores at rest (R) and after
standardized movement (M). Data are mean and standard deviation.
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Table 5
McGill Pain Questionnaire (MPQ) pain rating index (PR[) for sensory (S), affective (A), evaluative (E), miscellaneous (M) and total (T) scores, present pain
intensity (PPI) and number of words chosen (NWC)
MPQ scores Day 1 (24 h) post-op Day 2 (48 h) post-op Day 3 (72 h) post-op
Group I Group 2 Group 3 Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
PRI-S
PRI.A
PRI-E
PRI-M
PRI-T
PPI
NWC
8.0 + 7.0
0.7 + 1.1
t.t ! 1.2
1.7 + 2.5
11.5 + 10.1
1.3 + 0.8
7.O + 5.9
6.9 + 7.1
0.7 + 1.2
0.9 + 1.2
r.4 + 2.0
9.9 + 10.4
1.3 + 0.9
5.7 + 5.6
7.6 + 6.3
0.7 + 1.5
1.0 + 1.3
1.7 + 2.2
11.1 + 9.5
1.4 + 0.9
6.3 + 4.9
6.2 + 7.0
0.8 + 2.1
0.9 + 1.4
1.2 + 1.9
9.1 + 11.4
1.2 + r.3
5.8 + 7.3
44+ 5) 44+ 49,
0.7 + 1.4 0.4 + 1.0
0.5 + 0.8 0.5 + 1.0
1.6 + 2.6 l.l + 2.2
7.2+8.6 6.5+7.1
1.0 + 1.1 l.l + 1.0
4.0 + 4.5 3.8 + 4.1
4.0 + 5.7 4.4 + 5.3 2.6 + 4.0
0.3 + 0.7 0.3 + 0.7 0.1 + 0.3
0.6 + 1.1 0.6 + 1.1 0.2 + 0.5
0.6 + 1.4 0.5 + 0.8 0.5 + 1.0
5.5 + 7.8 5.9 ! 7.1 3.3 + 5.1
0.7 + 0.9 0.9 + 1.0 0.6 + 0.8
3.3 + 4.8 3.8 + 4.8 1.9 + 2.8
Data are mean + SD.
3. 8. Six-month follow-up interview
One hundred and eight of the 143 patients (15.57o)
were reached by telephone 6 months after surgery(n:34, 36, and 38 in groups 1-3, respectively). The
groups did not differ significantly in the most intense
pain they remembered having experienced after surgery
(Table 7) which was a remarkably accurate reflection of
their 24 h VAS-M pain scores (Fig. 5).
The overall incidence of pain was l0.5Vo (n : 15) with
no significant difference among the three groups (Table 7).
The pain was described as sharp, burning or aching and as
originating in deep tissue and at the scar. In general, the
intensity of pain was mild and all 15 patients reported not
taking analgesic medication for the pain. One patient in
group 2 reported that the pain interfered 'slightly' with his
everyday activities; the remaining 14 reported no inter-
ference at all.
4. Discussion
The results of the present study do not support the
hypothesis that pre-operative i.v. administration of the
NMDA receptor antagonist ketamine results in a clinically
meaningful reduction in pain or morphine consumption
when compared with a saline control condition or post-
incisional administration of i.v. ketamine. In the present
study, a bolus dose of 0.2 mg kg-l ketamine followed by
continuous infusion of 2.5 p"gkg-l min-1 for 80 min was
started 10 min before or 70 min after incision. This
amounted to approximately 30 mg ketamine administered
over the duration of the 3-h procedure. There was no
evidence that post-operative pain or analgesic use differed
as a function of pre-operative or post-incisional adminis-
tration of ketamine. Nor did this regimen reduce post-
operative cumulative morphine consumption or pain
compared with a saline control group that did not receive
ketamine.
However, between group comparisons of the regression
line slopes relating morphine and time support the idea that
pre-operative ketamine is associated with a late reduction in
the rate of morphine consumption beginning at 49 h after
surgery and extending to the end of the study, '72h after
surgery. The difference in the rate of morphine consumption
between group I and the other two groups on day 3 was
approximately 0.25 mg tr-t 6ig. 4) amounting to 6 mg less
of morphine over 24 h. Since this effect was observed two
days after ketamine administration (> 15 ketamine half
lives; Clements et al., 1982) in groups I andZ, it is likely not
related to the ongoing actions of the drug but rather to a
possible reduction in central sensitization.
The difference in the rate of morphine consumption in
favor ofthe pre-incisional group supports the idea that early
and late noxious intraoperative stimuli contribute differen-
tially to the establishment of central sensitization (Katz,
2003;Katz et al., 2003). In the present study, it appears that
the noxious events during the early intraoperative period
including incision and the following 70 min contribute to a
greater extent to central sensitization than do noxious late
intraoperative or post-operative stimuli. Furthermore, given
the absence of a difference in rate of morphine consumption
between groups 2 and 3, it would appear that the most
'. o... Group I
-{- Group 2
+ Group3
24 48 72
Arm
Hours after surgery
Fig. 6. von Frey touch and pain thresholds obtained 10 cm from the wound
dressing and at a control site on the forearm, Data are mean and standard
deviation.
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Table 6
Data [n (Vo)l from 2-week post-discharge follow-up
Follow-up measure Group 1 Group 2 Group 3
Days since surgery (meaf SD; 18.9 + 4.4
VAS pain at rest (mean + SD) 2.8 + 1.5
Pain-free on discharge (%) 25 (62.5)
Pain since discharge (7o) 23 (57.5)
Scar tender to touch (7o) 2l (52.5)
19.7 + 10.7 t9.6 + 4.6
3.0 + 1.7 2.9 + 1.9
24 (5s.8) 2s (6r.0)
30 (6e.8) 26 (63.4)
23 (s3.5) 22 (s3.7)
important contribution to central sensitization in the present
study originates in the effects of the barrage of noxious
impulses arising from incision and subsequent noxious
events. Nevertheless, the clinical significance of this effect
is small and the somewhat lower morphine consumption
was not accompanied by differences in pain hypersensitivity
as measured by von Frey filaments, by pain scores at rest or
after mobilization, or in the incidence and intensity of pain?
weeks and 6 months after surgery.
The present design thus compared an early vs. late
intraoperative start to NMDA receptor blockade by a low
dose of ketamine. The timing of administration of the
ketamine infusions and total dose of ketamine were
designed to reduce the incidence of adverse reactions.
Because of reports of psychotomimetic and emergence
reactions associated ketamine (Sethna et al., 1998; White
et al., 1982), we planned to stop the second infusion
approximately 20-30 min before the end of surgery so as to
minimize the potential occurrence of these adverse effects,
especially in group 2 patients. We anticipated the mean
duration ofthe radical prostatectomy procedure to be 3 h as
in our earlier study (Katz et al., 1994) so that running the
two infusions for approximately 80 min each translated into
Table 7
Six-month follow-uo data
Follow-up measure Group 1 Group 2 Group 3
stopping the second infusion on average 30 min before the
end of surgery (Table I and Fig. 1). Emergence reactions
were not observed: nor were hallucinations or other
psychotomimetic effects although one patient in group 2
reported having had vivid dreams.
The low dose ofketamine also appeared to have no effect
on intraoperative heart rate or blood pressure in contrast to
the results reported by Roytblat et al. (1993) showing a
marked reduction in intraoperative hemodynamics associ-
ated with a single pre-operative bolus dose of 0.15 mg kg-r
ketamine i.v. As shown in Figs. 2 and 3 isoflurane
requirements and hemodynamic responses did not signifi-
cantly differ among the three groups, nor between the first
and second infusions within groups I and 2. To our
knowledge, the only other study to compare low dose
ketamine (0.15mgkg-r) and saline also reported no
significant differences in intraoperative heart rate and
blood pressure (Hirata et al., 1995).
There are several possibilities that alone, or in various
combinations, may explain the lack of a clinically
significant pre-emptive or preventive effect of the fentanyl
and ketamine used in the present study. The first has to do
with the related issues of timing of ketamine administration
relative to incision and duration of NMDA receptor
blockade. Central sensitization is not only induced during
surgery but also post-operatively by inflammatory inputs
(Katz, 2003; Kissin, 2000). As discussed above, neither
group I nor group 2 received the ketamine infusion for the
duration of the surgical procedure and no ketamine was
given in the post-operative period. Thus, the modest effects
in rate of morphine consumption we observed might have
been enhanced had we started the infusion before surgery
and continued it throughout the procedure into the post-
operative period.
Secondly, the dose of ketamine used in the present study
may have been too small. Studies of abdominal surgery
patients have reported significant effects using bolus doses
that ranged between 0.15 and 2 mg kg-l and infusion rates
between 
-8 and 20 pgkg-l min-r lAida et al., 2000; Fu
et al., 1997; Kee et al., 1997; Roytblat et a1.,1993; Tverskoy
et al., 1994). Negative results have also been reported after
abdominal hysterectomy using a total ketamine dose
approximating the 30 mg used in the present study (Wild-
er-Smith et al., 1998). Other surgical procedures have
produced mixed results: the same small bolus dose of
0.15 mg kg-' ketamine produced an early opposite effect in
favor of the post-incision group after mastectomy (Adam
et al., 1999) and significantly lower post-operative mor-
phine requirements 48 h after anterior cruciate ligament
repair in patients treated with ketamine before or after
surgery compared with a placebo control group (Menigaux
et al., 2000). In addition, a considerable amount of blood
loss occured in all three groups (Table 2) which, together
with the associated fluid management, may have reduced
further the ketamine serum concentration in groups I and2.
It is possible that a larger dose of ketamine combined with
Follow up time in days 201.8 + 17.8
Most intense pain after surgery
PPr (0-5)
vRs (0-10)
Has pain at site of surgery 6 (17.6)
In (Vo)l
Taking medication [z ] 0
Pain interference in daily activities
Not at all [n (7o)] 6 (100)
2.1 + 0.6
5.1 + 1.9
2U.7 + 19.3
2.1 + 0.7
5.6 + 2.2
2 (s.6)
0
1 (s0)
I (50)
2.8 + 1.1
2.0 + 1.4
0.0 1 0.0
1.0 + 0.0
3.0 + 1.4
1.0 + 0.0
2.5 + 0.7
205.2 + 25.2
2.0 + o.9
5.1 + 2.5
1 (8.4)
0
7 (100)
0 (0)
3.4 + 3.0
3.9 + 2.7
0.0 + 0.0
0.4 + 0.5
4.9 + 2.8
1.7 + 1.5
3.1 + 1.5
Slightly [n (7o)]
VAS-rest pain
0 (0)
2.3 + 1.2
2.4 + 2.1
0.0 + 0.0
McGill Pain Questionnaire scores
PRI-sensory
PRI-affective
PRl-evaluative 0.6 + 0.5
PRI-total 3.0 + 2.1
Present pain intensity 1.4 + 0.5
Number of words chosen 2.2 + 1.3
Follow-up time and most intense pain are reported for all 108 patients
reached. The remaining variables show data only for patients reporting
pain. Data are mean + SD unless otherwise stated.
a continuous intravenous infusion would have resulted in
more clinically significant results in the present study.
A third reason for the lack ofa clinically significant effect
may have to do with the co-administration of fentanyl with
ketamine and more generally; the role of ketamine in
potentiating opioid analgesia by preventing or reducing
central sensitization. Our expectation was that adding low-
dose ketamine to a standard general anesthetic regimen
using fentanyl would produce enhanced antinociceptive
effects due to the combined actions of the two agents
operating at different receptor sites (Chapman and Dick-
enson, 1992: Dickenson, 1997), and in particular by
preventing or obtunding the NMDA-mediated state of
pain hypersensitivity that normally ensues following tissue
damage (Dickenson, 1997). However, the results of a recent
rat study in which epidural ketamine was combined with
various doses of morphine and fentanyl suggests that the
effects of ketamine may depend on the specific mu opioid
agonist (Hoffmann et aI., 2003). Whereas ketamine
potentiated the antinociceptive effects of morphine, it
antagonized the effects of fentanyl at several doses. The
mechanism by which this antagonistic effect occurred is not
known but may involve competition for active blood-brain
barrier transport proteins due to the high lipophilicity of
both ketamine and fentanyl, competition between ketamine
and fentanyl for the mu receptor, drug differences in mu
receptor subtype binding, or intracellular differences in
phosphorylation associated with specifi c opioid-ketamine
combinations (Hoffmann et al., 2003).
To date six studies have evaluated pre-emptive or
preventive effects of i.v. ketamine in combination with an
opioid. The clinical data do not point to a clear-cut
relationship between the relative efficacy of ketamine
when administered with various opioid agonists although
Hoffmann et al. (2003) suggested that lipophilicity may be a
factor. The two studies that administered ketamine in
combination with morphine found a significant opioid
sparing effect (Aida et al., 2000; Kee et al., 1997), and a
significant reduction in post-operative pain (Aida et al.,
2000) compared with a control group. The only other study
to have administered pre-operative ketamine with fentanyl
also found a significant opioid sparing effect in favor ofthe
ketamine treated patients compared with a saline control
group (Roytblat et al., 1993). The remaining three studies
did not find a pre-emptive or preventive effect when
ketamine was administered in combination with the fast-
acting opioids sufentanil (Adam et aI., 1999; Menigaux
et al., 2000) or alfentanil (Dahl et al., 2000). Interestingly,
co-administration of ketamine and alfentanil before or after
surgery resulted in greater pain intensity when compared
with a saline control group that received alfentanil
alone (Dahl et al., 2000). These results were opposite
in direction to what was predicted, and are consistent with
the suggestion that ketamine may have antagonized the
antinociceptive effects of the opioid (Hoffmann et a1.,2003).
Further studies are required to determine the relative
efficacy of ketamine in combination with various opioid
agonists.
The literature contains two competing hypotheses that
may, in part, help to explain the negative findings of the
present study. On the one hand, it is possible that the
fentanyl and other agents (e.g. nitrous oxide), administered
as part of the general anesthetic regimen, exerted subtle,
additive pre-emptive effects, which may have attenuated the
central sensitizing effects of surgery in all patients thereby
minimizing the effect size when comparing groups I and 2
with the control group.
On the other hand, recent evidence shows that under
certain conditions opioids activate pronociceptive systems
associated with acute opioid tolerance and opioid-induced
hyperalgesia (Celerier et al., 2000; Crain and Shen, 2000;
Kissin et al., 2000; Mao et al., 1995). These phenomena are
derived from an NMDA-receptor mediated mechanism
similar to that which occurs following tissue damaging
injury. Mu-opioid receptor agonists produce a sustained
increase in NMDA-activated currents by activating intra-
cellular protein kinase C which potentiates the NMDA
response by reducing the voltage-dependent Mg2+ block of
NMDA-receptor channels. In rats, pre-treatment with
ketamine prior to opioid administration and followed by
repeated ketamine injections prevented opioid-induced
hyperalgesia and acute tolerance to opioids (Laulin et al.,
2002). It is possible that administration of fentanyl to all
patients may have activated a pronociceptive system
thereby minimizing later inter-groups differences in post-
operative pain and morphine consumption. The subsequent
administration of ketamine to groups I and 2 after the
fentanyl may have been too late to prevent opioid-induced
NMDA-receptor activation.
Taken together, these results suggest that clinically
significant reductions in post-operative pain and analgesic
use are more likely to be found when ketamine is
administered preventively (Katz, 2003; McCartney et al.,
2004) before induction of anesthesia (prior to an opioid;
preferably morphine) and continuously throughout the
operation. In addition, use of the S(*) isomer of ketamine
may produce more substantial results. The S(*) isomer has
been shown to be 3-4 times more potent than the R(+)
isomer in producing anti-nociceptive effects and, in
equianalgesic doses, possibly to induce fewer psychotomi-
metic effects (Marietta et al.. 1917: Mathisen et al.. 1995:
White et al., 1985). These suggestions appear to be
supported by preliminary results (Snijdelaar et al., 2004).
In summary, pre-operative i.v. fentanyl plus a low-dose
i,v. ketamine infusion did not reduce cumulative morphine
consumption or pain, to a clinically significant extent, when
compared with the same regimen initiated 70 min after the
start of surgery or a fentanyl plus saline control condition.
Although the rate of morphine consumption on day 3 was
significantly lower in group 1 than in groups 2 and3,by 2
weeks and 6 months after surgery the three groups did not
differ significantly in pain incidence or intensity. Extending
the duration of the infusion to cover a longer period of
nociceptive activity, use of the S(*) isomer of ketamine,
and co-administering it in combination with morphine may
produce more clinically meaningful results.
Acknowledgements
The study was supported by Grants MT-12052 and
MOP-37845 from the Canadian Institutes of Health
Research (CIHR), Ontario, Canada, and a CIHR Investi-
gator Award to JK. JK is supported by a Canada Research
Chair in Health Psychology at York University. TJC is
supported by a CIHR Investigator Award. Presented in part
at the 20th Annual Scientific Meeting of the American Pain
Society, Phoenix, AZ, USA (April2l, 2001) and the Annual
Conference of the Canadian Pain Society, Montreal, QC,
Canada (May 10, 2001). We are grateful for the help
provided by the staff of the Department of Anesthesia and
Pain Management, Department of Urology and the PACU at
the Toronto General Hospital, Toronto, Ont., Canada. The
authors thank Tanya Constantine, Mariel Escover, Eileen
Halket Olivera, Karanovic, Keitha McMurray, and Bart
Mysliwiec for their expertise with patient care and/or help in
data scoring, entry and verification.
References
Adam F, Libier M, Oszustowicz T, Lefebvre D, Beal J, Meynadier J.
Preoperative small-dose ketamine has no preemptive analgesic effect
in patients undergoing total mastectomy. Anesth Analg 1999;89:
444-7.
Aida S, Yamakura T, Baba H, Taga K, Fukuda S, Shimoji K. Preemptive
analgesia by intravenous low-dose ketamine and epidural morphine in
gastrectomy: a randomized double-blind study. Anesthesiology 2000;
92:1624-30.
Brown BW, Brauner C, Chan A, Gutierrez D, Herson J, Lovato J, Polsley J.
STPLAN version 4.0: June, 1993. Calculations for sample sizes and
related problems. Houston, TX: The University of Texas M.D.
Anderson Cancer Center; 1993.
Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G.
Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect
of ketamine. Anesthesiology 2000;92:465 
-72.
Chapman V, Dickenson AH. The combination of NMDA antagonism and
morphine produces profound antinociception in the rat dorsal hom.
Brain Res 1992;57 3:321 
-3.
Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and
analgesic activity ofketamine in humans. J Pharm Sci 1982;11:539-42.
Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions
enhance morphine's analgesic potency and attenuate opioid
tolerance/dependence liability. Pain 2000;84: 121 
-3 1
Dahl V, Ernoe PE, Steen T, Raeder JC, White PF. Does ketamine have
preemptive effocts in women undergoing abdominal hysterectomy
procedures? Anesth Analg 2000;90:1419 
-22.
Dajczman E, Gordon A, Kriesman H, Wolklove N. Long-term postthor-
acotomy pain. Chest 1991;99 :27 0-4.
Dallal GE. DESIGN: a supplementary module for SYSTAT and
SYGRAPH, SYSTAT. Evanston, IL; 1988.
Dickenson AH. NMDA receptor antagonists: interactions with opioids.
Acta Anaesthesiol Scand 1997 :41:-lL2-5.
Fu ES, Miguel R, Scharf JE. Preemptive ketamine decreases postoperative
narcotic requirements in patients undergoing abdominal surgery,
Anesth Analg 1997;84: 1086-90.
Glantz SA. Primer of biostatistics: the program. New York: McGraw-Hill;
1997.
Hammersley JM, Handscomb DC. Monte Carlo methods. London:
Methuen: 1964.
Hirata S, Seo N, Murayama T, Fujiwara T, Sekiguchi M. Addition of low-
dose ketamine to general anesthesia does not improve cardiovascular
response during conventional abdominal surgery. Anesth Analg 1995;
81:1111-2.
Hoffmann VL, Baker AK, Vercauteren MP, Adriaensen HF, Meert TF.
Epidural ketamine potentiates epidural morphine but not fentanyl in
acute nociception in rats. Eur J Pain 20O3;7:121-30.
Katz J. Timing of treatment and pre-emptive analgesia. In: Rice A, Warfield
C, Justins D, Eccleston C, editors. Clinical pain management: acute
volume. London: Amold; 2003. p. 113-62.
Katz J, Melzack R. Measurement of pain. Surg Clin North Am 1999;79
231-52.
Katz J, Clairoux M, Kavanagh BP, Roger S, Nierenberg H, Redahan C,
Sandler AN. Pre-emptive lumbar epidural anaesthesia reduces post-
operative pain and patient-controlled morphine consumption after
lower abdominal surgery. Pain 1994;59:39 5 
-403.
Katz J, Cohen L, Schmid R, Chan VW, Wowk A. Postoperative morphine
use and hyperalgesia are reduced by preoperative but not intraoperative
epidural analgesia: implications for preemptive analgesia and the
prevention of central sensitization. Anesthesiology 2003;98:1449 
-60.
Kee WD, Khaw KS, Ma ML, Mainland PA, Gin T. Postoperarive analgesic
requirement after cesarean section: a comparison of anesthetic
induction with ketamine or thiopental. Anesth Analg 1997;85:1294-8.
Kissin I. Preemptive analgesia. Anesthesiology 2000;93: 1 138-43.
Kissin I, Bright CA, Bradley Jr. EL. The effect of ketamine on opioid-
induced acute tolerance: can it explain reduction ofopioid consumption
with ketamine-opioid analgesic combinations? Anesrh Analg 2000;91:
1483-8.
Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G.
The role of ketamine in preventing fentanyl-induced hyperalgesia
and subsequent acute morphine tolerance. Anesth Analg 2002;94:
1263-9.
Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine
tolerance: a current view of their possible interactions. Pain 1995;62:
259-74.
Marietta MP, Way WL, Castagnoli Jr. N, Trevor AJ. On the pharmacology
of the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther 1977;
202:157 
-65.
Mathisen LC, Skjelbred P, Skoglund LA, Oye I. Effect of ketamine, an
NMDA receptor inhibitor, in acute and chronic orofacial pain. pain
1995;61:.215-20.
McCartney CJL, Sinha A, Katz I. A qualitative systemaric review of the
role of the N-methyl-o-aspartate (NMDA) receptor antagonists in
preventive analgesia. Anesth Analg 2004;98: 1385 
-400.
Melzack R. The McGill Pain Questionnaire: major properties and scoring
methods. Pain 197 5:,1;277 
-99.
Menigaux C, Fletcher D, Dupont X, Guignard B, Guirimand F, Chauvin M.
The benefits of intraoperative small-dose ketamine on postoperative
pain after anterior cruciate ligament repair. Anesth Analg 2000;90:
129-35.
Roytblat L, Korotkoruchko A, Katz J, Glazer M, Greemberg L, Fisher A.
Postoperative pain: the effect of low-dose ketamine in addition to
general anesthesia. Anesth Analg 1993;77 :l 161 
- 
5.
Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose keramine in
the management of acute postoperative pain: a review of current
techniques and outcomes. Pain 1999;82:lll 
-25.
Sethna NF, Liu M, Gracely R, Bennett GJ, Max MB. Analgesic and
cognitive effects of intravenous ketamine-alfentanil combinations
versus either drug alone after intradermal capsaicin in normal subjects.
Anesth Analg 1998;86: 1250-6.
Snijdelaar DG, Cornelisse HB, Schmid RL, Katz J. A randomised,
controlled study of peri-operative low dose s(*)-ketamine in
-combination with postoperative patient-controlled s(+)-ketamine
and morphine after radical prostatectomy. Anaesthesia 2004;59:
222-8.
Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the State-
Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press
Inc.:1970.
Tverskoy M, Oz Y, Isakson A, Finger J, Bradley Jr. EL, Kissin I.
Preemptive effect of fentanyl and ketamine on postoperative pain and
wound hyperalgesia. Anesth Analg 1994;7 8:205 
-9.
Ware JEJ, Johnston SA, Davies-Avery A, Brook RH. Conceptualization
and measurement of health for adults in the Health Insurance Study.
Vol. III. Mental health (R-1987/3-HEW). Santa Monica, CA: RAND
Corporation; 1979.
Weinstein MC, Berwick DM, Goldman PA, Murphy JM, Barsky A. A
comparison of three psychiatric screening tests using receiver
operating characteristics (ROC) analysis. Med Carc 1989;2'7:
s93-607.
White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and
therapeutic uses. Anesthesiology 1982;56: 1 19-36.
White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ.
Comparative pharmacology of the ketamine isomers. Studies in
volunteers. Br J Anaesth 1985:57:197-203.
Wilcox GL. Excitatory neurotransmitters and pain. In: Bond MR, Charlton
JE, Woolf CJ, editors. Proceedings of the VI World Congress on Pain.
Amsterdam: Elsevier; 1991. p. 97 
-111 .
Wilder-Smith OH, Arendt-Nielsen L, Gaumann D, Tassonyi E, Rifat KR.
Sensory changes and pain after abdominal hysterectomy: a comparison
of anesthetic supplementation with fentanyl versus magnesium or
ketamine. Anesth Analg 1998;86:95- 101.
Woolf CJ, Chong MS. heemptive analgesia-treating postoperative pain
by preventing the establishment of central sensitization. Anesth Analg
1993:'77:362-79.
Woolf CJ, Thompson SW. The induction and maintenance of central
sensitization is dependent on N-methyl-o-aspartic acid receptor
activation; implications for the treatment of posrinjury pain hypersen-
sitivitv states. Pain 1997:.44:293 
-9.
